Hemogenyx Pharmaceuticals PLC announces Total Voting Rights

LONDON, UK / ACCESSWIRE / May 28, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 28 May 2021 …